IXICO (LON:IXI) Insider Mark Warne Buys 50,006 Shares

IXICO plc (LON:IXI) insider Mark Warne purchased 50,006 shares of the company’s stock in a transaction dated Wednesday, July 15th. The shares were acquired at an average price of GBX 8 per share, with a total value of £4,000.48.

IXICO Stock Down 3.0%

IXI stock opened at GBX 8 on Wednesday. The company has a current ratio of 2.83, a quick ratio of 4.90 and a debt-to-equity ratio of 5.22. The company’s 50 day moving average is GBX 8.21 and its 200 day moving average is GBX 8.71. The stock has a market cap of £17.52 million, a price-to-earnings ratio of -4.10, a price-to-earnings-growth ratio of -0.38 and a beta of 0.13. IXICO plc has a 1-year low of GBX 6.26 and a 1-year high of GBX 15.

IXICO (LON:IXI) last announced its earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share (EPS) for the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. The company had revenue of GBX 395 million for the quarter. Sell-side analysts predict that IXICO plc will post -289.3584879 EPS for the current fiscal year.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.